{"entity":{"type":"insider","cik":"0001855503","url":"/insider/0001855503","json_url":"/insider/0001855503.json","name":"Vida Ventures III-A, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":3,"first":"2022-01-11","last":"2025-09-16","span_basis":"filed_date"},"name_variants":[{"name":"Vida Ventures III-A, L.P.","source":"filing","n_filings":3,"first_seen":"2022-01-11","last_seen":"2025-09-16"}],"transactions":[{"id":4066224,"accession":"0001193125-25-204935","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-25-204935","line_url":"/filing/0001193125-25-204935","is_derivative":false,"issuer_cik":"0001296549","issuer_name":"LB PHARMACEUTICALS INC","issuer_ticker":"LBRX","issuer_name_source":null,"issuer_url":"/issuer/0001296549","owner_cik":null,"owner_name":"Belldegrun Arie; Vida Ventures GP III, L.L.C.; Vida Ventures III, L.P.; Vida Ventures III-A, L.P.; Vida Ventures Management Co. LLC","owner_display_name":"Belldegrun Arie","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":333333.0,"shares_display":"333,333","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":4999995.0,"total_display":"4,999,995.00","total_whole":"4,999,995","shares_owned_after":880214.0,"shares_owned_after_display":"880,214","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-12","filed_date":"2025-09-16","scope":"insider","n_lines":2},{"id":2892768,"accession":"0000950170-24-015479","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-015479","line_url":"/filing/0000950170-24-015479","is_derivative":false,"issuer_cik":"0001724489","issuer_name":"Kyverna Therapeutics, Inc.","issuer_ticker":"KYTX","issuer_name_source":null,"issuer_url":"/issuer/0001724489","owner_cik":null,"owner_name":"Vida Ventures GP III, L.L.C.; Vida Ventures III, L.P.; Vida Ventures III-A, L.P.; Vida Ventures, LLC","owner_display_name":"Vida Ventures GP III, L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":253136.0,"shares_display":"253,136","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":5568992.0,"total_display":"5,568,992.00","total_whole":"5,568,992","shares_owned_after":252553.0,"shares_owned_after_display":"252,553","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-02-12","filed_date":"2024-02-14","scope":"insider","n_lines":2},{"id":6840072,"accession":"0000899243-22-001657","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-001657","line_url":"/filing/0000899243-22-001657","is_derivative":false,"issuer_cik":"0001827087","issuer_name":"Vigil Neuroscience, Inc.","issuer_ticker":"VIGL","issuer_name_source":null,"issuer_url":"/issuer/0001827087","owner_cik":null,"owner_name":"Vida Ventures GP III, L.L.C.; Vida Ventures III, L.P.; Vida Ventures III-A, L.P.","owner_display_name":"Vida Ventures GP III, L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1675000.0,"shares_display":"1,675,000","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":23450000.0,"total_display":"23,450,000.00","total_whole":"23,450,000","shares_owned_after":5004393.0,"shares_owned_after_display":"5,004,393","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-11","filed_date":"2022-01-11","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001691082","name":"LB PHARMACEUTICALS INC","url":"/issuer/0001691082","role":"Ten percent owner","n_filings":1,"first_seen":"2025-09-16","last_seen":"2025-09-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001994702","name":"Kyverna Therapeutics, Inc.","url":"/issuer/0001994702","role":"Ten percent owner","n_filings":1,"first_seen":"2024-02-14","last_seen":"2024-02-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001827087","name":"Vigil Neuroscience, Inc.","url":"/issuer/0001827087","role":"Ten percent owner","n_filings":1,"first_seen":"2022-01-11","last_seen":"2022-01-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001855503","retrieved_at":"2026-08-22T23:18:07+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}